Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Fasinumab in Healthy Japanese and Caucasian Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 May 2016
Price :
$35
*